OPG Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-62482r |
| Product Name | OPG Recombinant Antibody |
| Applications |
IHC-P
IHC-F
IF(IHC-P)
IF(ICC)
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | A synthesized peptide derived from human TNFRSF11B |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | 1mg/ml |
| Purification | purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 4982 |
| Swiss Prot | O00300 |
| Subcellular location | Secreted |
| Synonyms | OCIF; OPG; PDB5; TR1; TR11B_HUMAN; TNFRSF11B; Osteoclastogenesis inhibitory factor; Osteoprotegerin; TNF receptor superfamily member 11b; tumor necrosis factor receptor superfamily, member 11b |
| Background | Acts as a decoy receptor for TNFSF11/RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local ratio between TNFSF11 and TNFRSF11B. |
| Application Dilution | |
| IHC-P | 1:100-500 |
| IHC-F | IHC-F1:100-500 |
| IF(IHC-P) | IFIHC-P1:100-500 |
| IF(ICC) | IFICC1:50-200 |
